Mckesson Corporation Intrinsic Value – Retain McKesson Stock for Long-Term Gains!

November 14, 2023

☀️Trending News

MCKESSON ($NYSE:MCK): McKesson Corporation is a leading global healthcare services and information technology provider that offers essential medicines, supplies, and technology solutions to the healthcare industry. Given the strong fundamentals and competitive strengths of McKesson, it is recommended that you retain your stock holdings for the present time. The company has a long-standing reputation for reliability and trustworthiness, making it an attractive stock for long-term investors.

Furthermore, McKesson’s diversified range of services gives it a competitive edge over other companies in the healthcare sector. It is therefore highly recommended that you retain your McKesson stock holdings for the present time.

Stock Price

Retaining McKesson Corporation stock for long-term gains is a wise move. On Monday, MCKESSON CORPORATION stock opened at $469.3 and closed at $470.6, up by 0.3% from the previous closing price of 469.3. This positive trend indicates that the company is doing well and is likely to continue its growth in the long term.

Furthermore, McKesson’s focus on expanding its presence in the healthcare industry is expected to reap significant rewards over time. Therefore, it makes sense to hold onto MCKESSON CORPORATION stock for long-term gains. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Mckesson Corporation. More…

    Total Revenues Net Income Net Margin
    291.1k 3.49k 1.2%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Mckesson Corporation. More…

    Operations Investing Financing
    4.91k -973 -4.37k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Mckesson Corporation. More…

    Total Assets Total Liabilities Book Value Per Share
    66.09k 67.56k -13.74
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Mckesson Corporation are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    7.5% 15.4% 1.6%
    FCF Margin ROE ROA
    1.5% -169.2% 4.4%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Mckesson Corporation Intrinsic Value

    GoodWhale has analyzed MCKESSON CORPORATION‘s financials and determined that its intrinsic value is around $350.8. This valuation was calculated using our proprietary Valuation Line, which considers a wide range of financial and market factors. Currently, MCKESSON CORPORATION stock is being traded at $470.6, which represents an overvaluation of 34.1%. This indicates that the stock is trading higher than its intrinsic value and may be a good time to consider selling or taking profits. Investors should conduct further research to determine if MCKESSON CORPORATION stock is the right fit for their portfolio. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    In the healthcare sector, McKesson Corp competes against Cardinal Health Inc, AmerisourceBergen Corp, and Sigma Healthcare Ltd. These companies are all major players in the healthcare industry, and each one brings something unique to the table. However, McKesson Corp is the largest of these companies, and its size gives it a significant competitive advantage.

    – Cardinal Health Inc ($NYSE:CAH)

    Cardinal Health Inc is a healthcare services and products company that operates in two segments: Pharmaceutical and Medical. The company’s Pharmaceutical segment includes sales of branded, generic and over-the-counter pharmaceutical products, as well as nuclear pharmacy services. The Medical segment provides a range of medical products and services, including surgical and medical products, medical devices and laboratory products and services. Cardinal Health Inc has a market cap of 18.55B as of 2022. The company’s Return on Equity for the same period is 55.12%.

    – AmerisourceBergen Corp ($NYSE:ABC)

    AmerisourceBergen is one of the world’s largest pharmaceutical services companies. It offers a range of services and products to healthcare providers and pharmaceutical companies. The company has a market cap of 29.64B as of 2022 and a return on equity of 417.0%. AmerisourceBergen is a publicly traded company listed on the New York Stock Exchange.

    – Sigma Healthcare Ltd ($ASX:SIG)

    Sigma Healthcare is a leading full-line wholesale and distribution company that services pharmacies across Australia. The company has a market capitalisation of $693.83 million as of March 2022 and a return on equity of 0.46%. Sigma Healthcare is a diversified healthcare company with operations in both pharmacy and hospital sectors. The company’s primary activities include the wholesale distribution of pharmaceuticals, medical and surgical supplies. Sigma Healthcare also owns and operates a number of community pharmacies across Australia.

    Summary

    McKesson Corporation is a leading healthcare services and information technology company that offers a wide range of products and services to its customers. The company’s strong financials, solid business model and consistent growth in sales make it an attractive long-term investment.

    In addition, the company’s strategic acquisitions have strengthened its market position and provided a competitive edge. McKesson also enjoys strong relationships with key government agencies, insurance companies and healthcare providers, which further strengthens its competitive position. Investors should consider the company’s continued growth prospects and attractive dividend yield as they make their investment decisions.

    Recent Posts

    Leave a Comment